Single-Agent Epirubicin as Primary Chemotherapy in T2–T3, N0–N2, M0 Breast Carcinoma: 6-Year Follow-Up
Barni, S., Piazza, E., Frontini, L., Visini, M., Ardizzoia, A., Grassi, M.M., Nosenzo, M.A., Mandalà, M., Biasioli, R., Freddi, E., Lucani, L., Recalcati, A., Pravettoni, A., Sala, R., Rezzani, C., Villa, S., Trabucchi, E.
Published in Oncology (01.01.2004)
Published in Oncology (01.01.2004)
Get full text
Journal Article